| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/19/2001 | US6248742 Administering dna protective agent/anticarcinogenic agent for treatment of oxidative stress manifested in infections and inflammations |
| 06/19/2001 | US6248741 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 06/19/2001 | US6248739 Quinolinecarboxamides as antiviral agents |
| 06/19/2001 | US6248738 Isoquinolines as urokinase inhibitors |
| 06/19/2001 | US6248737 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects |
| 06/19/2001 | US6248736 Dna polymerase inhibitors effective against herpesviruses |
| 06/19/2001 | US6248735 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist |
| 06/19/2001 | US6248734 Use of photodynamic therapy for prevention of secondary cataracts |
| 06/19/2001 | US6248732 Administering mixture of activated vitamin d and vitamin c to eye to treat post ophthalmic surgery tissue deterioration |
| 06/19/2001 | US6248731 Stabilized aspirin compositions and method of preparation for oral & topical use |
| 06/19/2001 | US6248729 Combination of an ADP-receptor blocking antiplatelet drug and antihypertensive drug and a method for preventing a cerebral infarction employing such combination |
| 06/19/2001 | US6248728 Ingestion of phosphatidylcholinyl ester or ether derivative as a food or beverage supplement |
| 06/19/2001 | US6248726 Method of peritoneal dialysis using glucose polymer solutions |
| 06/19/2001 | US6248718 Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity |
| 06/19/2001 | US6248717 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248576 Histidinol dehydrogenase |
| 06/19/2001 | US6248559 Polynucleotide which encodes enzyme of defined amino acid sequence; treatment and prevention of alzheimer's disease; drug screening; enzyme inhibitors; recombinant production of enzyme |
| 06/19/2001 | US6248556 Nucleotide sequence of guanosine triphosphate-binding protein from staphylococcus; diagnosis of infections; drug screening; bactericides; bacteriostats; vaccines; probes; primers; vectors; host cells |
| 06/19/2001 | US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors |
| 06/19/2001 | US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/19/2001 | US6248375 Food bar |
| 06/19/2001 | US6248371 Tuberculosis |
| 06/19/2001 | US6248368 Administering magnesium salt |
| 06/19/2001 | US6248367 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248361 Water-soluble folic acid compositions |
| 06/19/2001 | US6248360 Complexes to improve oral absorption of poorly absorbable antibiotics |
| 06/19/2001 | US6248359 Sustained release |
| 06/19/2001 | US6248358 Bioadhesive progressive hydration tablets and methods of making and using the same |
| 06/19/2001 | US6248356 Immunotherapeutic anti-cancer pharmaceutical compositions |
| 06/19/2001 | US6248355 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation |
| 06/19/2001 | US6248354 Containing retinoid agent |
| 06/19/2001 | US6248352 Compositions containing lipid compounds derived from sphingoid bases, their process of preparation |
| 06/19/2001 | US6248350 Antiinflammatory analgesic patch |
| 06/19/2001 | US6248347 Calcium assimilation accelerator and calcium-supplementing diet comprising and a method for accelerating calcium assimilation |
| 06/19/2001 | US6248346 Chewing gum and production of the same |
| 06/19/2001 | US6248345 Prolonged anesthesia in joints and body spaces |
| 06/19/2001 | US6248343 Mixture of triclosan and plant extract |
| 06/19/2001 | US6248341 Method of treating topical angiogenesis-related disorders |
| 06/19/2001 | US6248334 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/19/2001 | US6248326 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
| 06/19/2001 | US6248318 Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| 06/19/2001 | US6248309 Synergistic mixture containing bactericide |
| 06/19/2001 | US6248308 Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| 06/19/2001 | US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 06/19/2001 | US6248305 Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use |
| 06/19/2001 | CA2219050C Polyamine derivatives as radioprotective agents |
| 06/19/2001 | CA2191129C Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
| 06/19/2001 | CA2190973C Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 06/19/2001 | CA2172187C Method of incorporating drugs into a polymer component of stents |
| 06/19/2001 | CA2136447C Selective cell inactivation in blood |
| 06/19/2001 | CA2125964C Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists |
| 06/19/2001 | CA2095444C Fused pyrazine derivatives |
| 06/19/2001 | CA2040248C Method of inhibiting gastric acid secretion |
| 06/19/2001 | CA2028048C Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol |
| 06/19/2001 | CA2027351C Emulsion of lipid containing a prostaglandin analogue |
| 06/19/2001 | CA2021116C Topical compositions containing live yeast cell derivative and other topically active medicinal ingredients |
| 06/19/2001 | CA2013893C Tetrahydrobenz¬c,d|indole serotonin agonists |
| 06/19/2001 | CA2008856C Tocols as adjuvant in vaccine |
| 06/19/2001 | CA1341260C Pharmaceutical and/or dietary compsitions containing l-carnitine and l- lysine |
| 06/19/2001 | CA1341256C Combination of pyrimidine derivatives and non steroidal anti-inflammatory agents to induce and stimulate hair growth and reduce hair loss |
| 06/14/2001 | WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 06/14/2001 | WO2001042459A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 06/14/2001 | WO2001042457A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses |
| 06/14/2001 | WO2001042444A2 Methods for expression of genes in primates |
| 06/14/2001 | WO2001042443A1 Method for modifying genetic characteristics of an organism |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042275A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 06/14/2001 | WO2001042274A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/14/2001 | WO2001042272A2 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 06/14/2001 | WO2001042265A2 N6 heterocyclic 8-modified adenosine derivatives |
| 06/14/2001 | WO2001042263A2 Oligosaccharide mixture |
| 06/14/2001 | WO2001042262A2 Antithrombotic compound |
| 06/14/2001 | WO2001042256A1 ANALOGS OF (1S, cis)-4-(2-AMINO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL AS ANTIVIRAL |
| 06/14/2001 | WO2001042255A1 (1R,CIS)-4-(4-AMINO-7H-PYRROLO'2,3-I(D) ! PYRIMIDINE-7-YL)-2-CYCLOPENTENE-1-METHANOL DERIVATIVES AS ANTIVIRAL |
| 06/14/2001 | WO2001042252A1 New aminopropylphosphinic acids |
| 06/14/2001 | WO2001042246A2 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 06/14/2001 | WO2001042245A1 Neurotrophic bicyclic diamides |
| 06/14/2001 | WO2001042242A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042238A1 Heterocyclic derivatives |
| 06/14/2001 | WO2001042237A1 3-methyl-chromane or thiochromane derivatives |
| 06/14/2001 | WO2001042236A1 Metal salts of 3-methyl-chromane or thiochromane derivatives |
| 06/14/2001 | WO2001042231A2 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/14/2001 | WO2001042228A1 Macrocyclic compounds and their use |
| 06/14/2001 | WO2001042225A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | WO2001042215A1 4-pyridinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | WO2001042213A1 Urea compounds having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042212A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042210A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/14/2001 | WO2001042207A2 Novel methods for the treatment and prevention of ileus |